COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 574: Articles 5731-5740  | Next

The Smoldering Pandemic: Self-Reported Prevalence Assessment of Prolonged Grief Disorder. A cross sectional study of bereaving adults during the Covid Pandemic in Pakistan.
Siddiqua, A., Ahmad, S., Zeeshan, D. M., Nawaz, I., Rao, A.
10.1101/2023.01.10.23284300 — Posted: 2023-01-11
ADAPTIVE TIME LOCATION SAMPLING FOR COMPASS, A SARS-COV-2 PREVALENCE STUDY IN FIFTEEN DIVERSE COMMUNITIES IN THE UNITED STATES
Zangeneh, S. Z., Skalland, T., Yuhas, K., Emel, L., Tapsoba, J. D. D., Reed, D., Amos, C., Donnell, D., Moore, A., Justman, J.
10.1101/2023.01.10.23284400 — Posted: 2023-01-11
Exosome based multivalent vaccine: achieving potent immunization, broaden reactivity and T cell response with nanograms of proteins without any adjuvant.
Cacciottolo, M., Nice, J. B., Li, Y., LeClaire, M. J., Twaddle, R., Mora, C. L., Adachi, S. Y., Chin, E. R., Young, M., Angeles, J., Elliott, K., Sun, M.
10.1101/2023.01.10.523356 — Posted: 2023-01-11
Impact of COVID-19 pandemic on cancer screening in Denmark: A register-based study
Nonboe, M. H., Napolitano, G., Schroll, J. B., Vejborg, I., Waldstroem, M., Lynge, E.
10.1101/2023.01.03.22277971 — Posted: 2023-01-11
Genetic determinants of severe COVID-19 in young Asian and Middle Eastern patients
Badla, B., Hanifa, M., Jain, R., El Naofal, M., Halabi, N., Yaslam, S., Ramaswamy, S., Taylor, A., Al Falasi, R., Shenbagam, S., Khansaheb, H., Al Suwaidi, H., Nowotny, N., Popatia, R., Alsheikh-Ali, A., Al Khayat, A., Loney, T., Al Dabal, L., Abou Tayoun, A. N.
10.1101/2023.01.11.23284427 — Posted: 2023-01-11
Effectiveness of an eHealth Intervention for Reducing Psychological Distress and Increasing COVID-19 Knowledge and Protective Behaviors among Ethnoracially Diverse Sexual and Gender Minority Adults: A Quasi-experimental Study (#SafeHandsSafeHearts)
Newman, P. A., Chakrapani, V., Massaquoi, N., Williams, C. C., Tharao, W., Tepjan, S., Roungprakhon, S., Forbes, J., Sebastian, S., Akkakanjanasupar, P., Aden, M.
10.1101/2023.01.09.23284380 — Posted: 2023-01-11
Validation of a MALDI-TOF MS method for SARS-CoV-2 detection on the Bruker Biotyper and nasopharyngeal swabs. A Brazil - UK collaborative study.
Lovison, O. v. A., Grigaite, R., Zempulski Volpato, F. C., Iles, J. K., Lacey, J., Barreto, F., Pandiri, S. R., Balzan, L. d. L. R., Cantarelli, V. V., Barth, A. L., Martins, A. F., Iles, R. K.
10.1101/2023.01.09.23284367 — Posted: 2023-01-11
Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1
James-Pemberton, P., Kohli, S., Westlake, A., Antill, A., Hunt, J., Olkhov, R., Shaw, A.
10.1101/2023.01.11.23284431 — Posted: 2023-01-11
The impacts of COVID-19 and its policy response on access and utilization of maternal and child health services in Tanzania: a mixed methods study
Shayo, E. H., Nassor, N. K., Mboera, L. E. G., Ngadaya, E., Mangesho, P., Bakari, M., Urassa, M., Seif, M., Tarimo, C., Masemo, A., Mmbaga, B. T., O'Sullivan, N., McCoy, D., Russo, G.
10.1101/2023.01.11.23284423 — Posted: 2023-01-11
Interleukin-1 receptor antagonist gene (IL1RN) variants modulate the cytokine release syndrome and mortality of SARS-CoV-2
Attur, M. G., Petrilli, C. M., Adhikari, S., Iturrate, E., Li, X., Tuminello, S., Hu, N., Chakravarti, A., Beck, D. B., Abramson, S. B.
10.1101/2023.01.09.23284348 — Posted: 2023-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).